|
Volumn 115, Issue 2, 2001, Pages 266-270
|
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon
a a a a |
Author keywords
Bone marrow; CD56; EBV; EBV encoded early RNA; Epstein Barr virus; In situ hybridization; Nasal lymphoma; Nasopharyngeal lymphoma; Natural killer cell; NK cell lymphoma
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CD56 ANTIGEN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
METHOTREXATE;
PREDNISOLONE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
BIOPSY;
BONE MARROW;
CLINICAL ARTICLE;
EPSTEIN BARR VIRUS;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION;
LYMPHOMA;
MALE;
NASOPHARYNX TUMOR;
NATURAL KILLER CELL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
VIRUS DETECTION;
ADULT;
AGED;
AGED, 80 AND OVER;
AMSACRINE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
BONE MARROW;
CHEMOTHERAPY, ADJUVANT;
CYCLOPHOSPHAMIDE;
CYTARABINE;
EPIRUBICIN;
ETOPOSIDE;
FEMALE;
HUMANS;
IMMUNOENZYME TECHNIQUES;
IN SITU HYBRIDIZATION;
KILLER CELLS, NATURAL;
LYMPHOMA;
MALE;
METHOTREXATE;
MIDDLE AGED;
NOSE NEOPLASMS;
PREDNISONE;
RADIOTHERAPY;
RNA, VIRAL;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 0035126174
PISSN: 00029173
EISSN: None
Source Type: Journal
DOI: 10.1309/E5PR-6A9R-Q02N-8QVW Document Type: Article |
Times cited : (57)
|
References (17)
|